Literature DB >> 33440658

MG53, A Tissue Repair Protein with Broad Applications in Regenerative Medicine.

Zhongguang Li1,2, Liyang Wang2, Huimin Yue2, Bryan A Whitson1, Erin Haggard1, Xuehong Xu2, Jianjie Ma1.   

Abstract

Under natural conditions, injured cells can be repaired rapidly through inherent biological processes. However, in the case of diabetes, cardiovascular disease, muscular dystrophy, and other degenerative conditions, the natural repair process is impaired. Repair of injury to the cell membrane is an important aspect of physiology. Inadequate membrane repair function is implicated in the pathophysiology of many human disorders. Recent studies show that Mitsugumin 53 (MG53), a TRIM family protein, plays a key role in repairing cell membrane damage and facilitating tissue regeneration. Clarifying the role of MG53 and its molecular mechanism are important for the application of MG53 in regenerative medicine. In this review, we analyze current research dissecting MG53's function in cell membrane repair and tissue regeneration, and highlight the development of recombinant human MG53 protein as a potential therapeutic agent to repair multiple-organ injuries.

Entities:  

Keywords:  TRIM protein; acute kidney injury; acute lung injury; cell membrane repair; muscular dystrophy; myocardial infarction

Year:  2021        PMID: 33440658      PMCID: PMC7827922          DOI: 10.3390/cells10010122

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  80 in total

1.  Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair.

Authors:  Xianhua Wang; Wenjun Xie; Yi Zhang; Peihui Lin; Liang Han; Peidong Han; Yanru Wang; Zheng Chen; Guangju Ji; Ming Zheng; Noah Weisleder; Rui-Ping Xiao; Hiroshi Takeshima; Jianjie Ma; Heping Cheng
Journal:  Circ Res       Date:  2010-05-13       Impact factor: 17.367

Review 2.  An emergency response team for membrane repair.

Authors:  Paul L McNeil; Tom Kirchhausen
Journal:  Nat Rev Mol Cell Biol       Date:  2005-06       Impact factor: 94.444

3.  From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.

Authors:  Lars Klinge; Steve Laval; Sharon Keers; Faye Haldane; Volker Straub; Rita Barresi; Kate Bushby
Journal:  FASEB J       Date:  2007-03-15       Impact factor: 5.191

4.  Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic Homeostasis.

Authors:  Hong-Kun Wu; Yan Zhang; Chun-Mei Cao; Xinli Hu; Meng Fang; Yuan Yao; Li Jin; Gengjia Chen; Peng Jiang; Shuo Zhang; Ruisheng Song; Wei Peng; Fenghua Liu; Jiaojiao Guo; Lifei Tang; Yanyun He; Dan Shan; Jin Huang; Zhuan Zhou; Dao Wen Wang; Fengxiang Lv; Rui-Ping Xiao
Journal:  Circulation       Date:  2019-02-12       Impact factor: 29.690

5.  MG53 constitutes a primary determinant of cardiac ischemic preconditioning.

Authors:  Chun-Mei Cao; Yan Zhang; Noah Weisleder; Christopher Ferrante; Xianhua Wang; Fengxiang Lv; Yi Zhang; Ruisheng Song; Moonsun Hwang; Li Jin; Jiaojiao Guo; Wei Peng; Geng Li; Miyuki Nishi; Hiroshi Takeshima; Jianjie Ma; Rui-Ping Xiao
Journal:  Circulation       Date:  2010-06-01       Impact factor: 29.690

6.  Defective membrane repair in dysferlin-deficient muscular dystrophy.

Authors:  Dimple Bansal; Katsuya Miyake; Steven S Vogel; Séverine Groh; Chien-Chang Chen; Roger Williamson; Paul L McNeil; Kevin P Campbell
Journal:  Nature       Date:  2003-05-08       Impact factor: 49.962

7.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

Review 8.  Dysferlin in membrane trafficking and patch repair.

Authors:  Louise Glover; Robert H Brown
Journal:  Traffic       Date:  2007-06-05       Impact factor: 6.215

9.  MG53 anchored by dysferlin to cell membrane reduces hepatocyte apoptosis which induced by ischaemia/reperfusion injury in vivo and in vitro.

Authors:  Weifeng Yao; Haobo Li; Xue Han; Chaojin Chen; Yihan Zhang; Wai Lydia Tai; Zhengyuan Xia; Ziqing Hei
Journal:  J Cell Mol Med       Date:  2017-04-12       Impact factor: 5.310

Review 10.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

View more
  8 in total

Review 1.  The Sarcoplasmic Reticulum of Skeletal Muscle Cells: A Labyrinth of Membrane Contact Sites.

Authors:  Daniela Rossi; Enrico Pierantozzi; David Osamwonuyi Amadsun; Sara Buonocore; Egidio Maria Rubino; Vincenzo Sorrentino
Journal:  Biomolecules       Date:  2022-03-23

2.  MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression.

Authors:  Jianxun Yi; Ang Li; Xuejun Li; Kiho Park; Xinyu Zhou; Frank Yi; Yajuan Xiao; Dosuk Yoon; Tao Tan; Lyle W Ostrow; Jianjie Ma; Jingsong Zhou
Journal:  Antioxidants (Basel)       Date:  2021-09-25

Review 3.  The Emerging Roles of Tripartite Motif Proteins (TRIMs) in Acute Lung Injury.

Authors:  Yingjie Huang; Yue Xiao; Xuekang Zhang; Xuan Huang; Yong Li
Journal:  J Immunol Res       Date:  2021-10-19       Impact factor: 4.818

4.  MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma.

Authors:  Pranav Gupta; Haichang Li; Guan-Nan Zhang; Anna Maria Barbuti; Yuqi Yang; Pei-Hui Lin; Chuanxi Cai; Tao Tan; Jianjie Ma; Zhe-Sheng Chen
Journal:  Int J Biol Sci       Date:  2022-08-15       Impact factor: 10.750

5.  Cellular Function of TRIM E3 Ubiquitin Ligases in Health and Disease.

Authors:  Germana Meroni; Solange Desagher
Journal:  Cells       Date:  2022-01-12       Impact factor: 6.600

6.  MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.

Authors:  Haichang Li; Pei-Hui Lin; Pranav Gupta; Xiangguang Li; Serena Li Zhao; Xinyu Zhou; Zhongguang Li; Shengcai Wei; Li Xu; Renzhi Han; Jing Lu; Tao Tan; Dong-Hua Yang; Zhe-Sheng Chen; Timothy M Pawlik; Robert E Merritt; Jianjie Ma
Journal:  Mol Cancer       Date:  2021-09-14       Impact factor: 27.401

7.  TRIM72 exerts antitumor effects in breast cancer and modulates lactate production and MCT4 promoter activity by interacting with PPP3CA.

Authors:  Zheng Wang; Haixia Li; Hongxia Wang; Xin Li; Qiong Zhang; Haifang Wang; Kui Li; Yurong Qiu
Journal:  Anticancer Drugs       Date:  2022-06-01       Impact factor: 2.248

8.  MG53 inhibits angiogenesis through regulating focal adhesion kinase signalling.

Authors:  Jinling Dong; Haiyan Zhou; Yongjie Li; Rong Li; Ni Chen; Youkun Zheng; Xin Deng; Mao Luo; Jianbo Wu; Liqun Wang
Journal:  J Cell Mol Med       Date:  2021-07-09       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.